← Open Payments lookup

FLOR RANGEL: Open Payments

NPI 1689392649 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$550 in 22 payments from 9 companies in 2025. Trend: 2023 $1,251 · 2024 $1,110 · 2025 $550

Food & beverage: $550
CompanyPaymentsAmount
Dexcom, Inc.6$190
Novo Nordisk Inc5$186
Abbott Laboratories3$51
AstraZeneca Pharmaceuticals LP2$34
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$28
Boehringer Ingelheim Pharmaceuticals, Inc.1$17
Phathom Pharmaceuticals, Inc.1$16
TOLMAR, INC.1$15
Currax Pharmaceuticals LLC1$14

Products named: DEXCOM G7 GSS (161), Ozempic, Dexcom G6 Transmitter, FARXIGA, XIFAXAN, Wegovy, JARDIANCE, PROCLAIM.

Industry payments across TX — which companies pay providers there.